Insider Shareholders with Direct Ownership of Capricor Therapeutics, Inc. (CAPR)
This section provides a comprehensive overview of the insiders with direct ownership of Capricor Therapeutics, Inc. (CAPR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CAPRICOR THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,798,507 | 0 | 7,090,351 $101 Million | 1 |
Sep 20, 2024
Added 28.3%
|
|
|
Linda Marban
CHIEF EXECUTIVE OFFICER |
20,749 | 0 | 198,604 $2.83 Million | 1 |
May 12, 2023
Added 9.46%
|
| 189,318 | 76,440 | 133,269 $1.9 Million | 6 |
Aug 14, 2023
Reduced 3.17%
|
|
| 104,791 | 45,990 | 81,692 $1.16 Million | 9 |
Aug 07, 2024
Added 29.39%
|
|
| 29,305 | 11,761 | 62,147 $886,216 | 4 |
Feb 21, 2023
Reduced 0.72%
|
|
| 56,856 | 0 | 56,856 $810,766 | 4 |
Apr 23, 2024
Added 34.54%
|
|
|
Karen Krasney
EVP, GENERAL COUNSEL |
26,932 | 0 | 28,047 $399,950 | 2 |
Dec 13, 2024
Added 22.19%
|
| 16,856 | 6,300 | 10,556 $150,528 | 3 |
Feb 14, 2023
Added 11.72%
|
|
|
Anthony Bergmann
CHIEF FINANCIAL OFFICER |
5,520 | 0 | 5,723 $81,609 | 2 |
Jan 02, 2025
Added 36.87%
|
| 5,000 | 0 | 5,000 $71,300 | 1 |
Oct 06, 2023
Added 50.0%
|
|
| 87,291 | 87,791 | 0 $0 | 6 |
Apr 17, 2023
Reduced 100.0%
|